SCHEMBL8286154

SCHEMBL8286154

CC(C)c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.42
MAPK13 O15264 1/20 0.38
MAPK12 P53778 1/20 0.38
MAPK11 Q15759 1/20 0.38
MAPK14 Q16539 1/20 0.38
CDK4 P11802 2/20 0.36
CCND1 P24385 2/20 0.36
CCND2 P30279 2/20 0.36
CCND3 P30281 2/20 0.36
GAA P10253 3/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
ALDH1A1 P00352 4/20 0.35
PDE11A Q9HCR9 1/20 0.35
KCNJ6 P48051 3/20 0.35
KCNJ5 P48544 3/20 0.35
KCNJ3 P48549 3/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286151 0.86 GSK3B (0.36) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL5872050 0.84 GAA (0.44) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287949 0.83 GSK3B (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287482 0.83 GSK3B (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8362929 0.83 PIK3CA (0.44) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8362924 0.82 GSK3B (0.39) GSK3BMAPK13MAPK12MAPK11MAPK14
SCHEMBL8285298 0.82 GSK3B (0.39) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287197 0.82 EGFR (0.43) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL5871843 0.82 MAT2A (0.40) GSK3BCDK4CCND1CCND2CCND3
SCHEMBL8287576 0.81 GSK3B (0.39) GSK3BCDK4CCND1CCND2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed